Magna International Inc. Announces Date For Third Quarter 2026 Results Webcast
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailAURORA, Ontario, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Magna International Inc. (TSX:MG) (NYSE:MGA)
MAGNA INTERNATIONAL INC.
ANNOUNCES DATE FOR THIRD QUARTER 2026 RESULTS WEBCAST
FRIDAY, OCTOBER 30, 2026 @ 8:00 AM ET
| LIVE AUDIO WEBCAST & REPLAY* | ||
| Click here to register and access replay: https://events.q4inc.com/attendee/258579312 | ||
| DIAL-IN DETAILS | ||
| USA Toll-Free: | 1-833-461-5787 | |
| International Toll: | 1-585-542-9983 | |
| Meeting ID: | 258579312 | |
| Slide presentation will be available on our website Investors | Magna prior to the call | ||
| *Note: Replay available 2 hours after call until November 6, 2026 | ||
INVESTOR CONTACT
Louis Tonelli, Vice-President, Investor Relations
[email protected] 905-726-7035
WEBCAST CONTACT
Nancy Hansford, Executive Assistant, Investor Relations
[email protected] 905-726-7108
ABOUT MAGNA
Magna is one of the world’s largest automotive suppliers and a trusted partner to automakers in the industry’s most critical markets—North America, Europe, and Asia. With operations in 28 countries, we combine global scale with trusted reliability and proven execution. Backed by nearly seven decades of experience, we bring together deep manufacturing expertise with innovative vehicle systems to deliver performance, safety, and quality.
For further information about Magna (NYSE:MGA; TSX:MG), please visit www.magna.com or follow us on social.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Libtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)
- Cryptocurrency News: Solana Goes 85x Faster as Pepeto Early Buyers Line Up for a Run
- New data on Lilly's investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell lung cancer
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
